Mimedx (MDXG) Net Cash Flow Growth (3y) (2014 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Net Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | -9.45% |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn | -16.59% |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn | -0.80% |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn | 60.16% |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | -85.83% |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | 43.26% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 1.60% |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn | -26.30% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 269.22% |
| 10 | Mimedx | 673.21 Mn | 537.37 Mn | 44.38 Mn | -51.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -51.41% |
| Mar 31, 2026 | -10.31% |
| Dec 31, 2025 | 74.44% |
| Sep 30, 2025 | 219.02% |
| Jun 30, 2025 | 80.89% |
| Mar 31, 2025 | 29.60% |
| Dec 31, 2024 | 49.89% |
| Sep 30, 2024 | 52.25% |
| Jun 30, 2024 | 329.46% |
| Mar 31, 2024 | -43.51% |
| Dec 31, 2023 | 77.79% |
| Sep 30, 2023 | -40.68% |
| Jun 30, 2023 | 71.56% |
| Mar 31, 2023 | 32.74% |
| Dec 31, 2022 | 33.80% |
| Sep 30, 2022 | 31.13% |
| Jun 30, 2022 | -26.96% |
| Mar 31, 2022 | 12.00% |
| Dec 31, 2021 | -467.95% |
| Sep 30, 2021 | 98.13% |